Kay Lund were postdoctoral researchers working in Joel Habener's laboratory at Massachusetts General Hospital
In the early 2000s, I changed my degree track from graphic design to biochemistry and nursing with a plan to go to medical school
Beginning July 1, 2026, the Medicare GLP-1 Bridge Program may allow eligible Medicare Part D patients to access certain obesity-indicated GLP-1 medications, including Foundayo, Wegovy, and certain Zepbound formulations, for no more than $50 per month through December 31, 2027
Clinical trials have demonstrated efficacy across diverse body mass index (BMI) ranges
Step 5: Dispose of the needle safely Place the used needle (or the entire single-use pen) into an approved sharps container
What This Means For Patients (Practical Takeaways) The rapid expansion of GLP-1 use is reshaping both clinical care and insurance coverage